Pembrolizumab for gastric or gastroesophageal junction adenocarcinoma [ID1305]

  • Discontinued
  • GID-TA10244

Documents

Documents created during the development process.

Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators